Supreme Petrochem [SUPPETRO] vs Neuland Laboratories [NEULANDLAB] Detailed Stock Comparison
Supreme Petrochem
BSE
Loading...
Neuland Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Supreme Petrochem wins in 8 metrics, Neuland Laboratories wins in 7 metrics, with 0 ties. Supreme Petrochem appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Supreme Petrochem | Neuland Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 150.56 | 111.11 | Neuland Laboratories |
| Price-to-Book Ratio | 5.62 | 12.80 | Supreme Petrochem |
| Debt-to-Equity Ratio | 0.12 | 10.31 | Supreme Petrochem |
| PEG Ratio | 3.83 | -1.29 | Neuland Laboratories |
| EV/EBITDA | 7.63 | 83.57 | Supreme Petrochem |
| Profit Margin (TTM) | 23.25% | 13.24% | Supreme Petrochem |
| Operating Margin (TTM) | N/A | 4.88% | N/A |
| EBITDA Margin (TTM) | N/A | 4.88% | N/A |
| Return on Equity | 219.17% | 17.06% | Supreme Petrochem |
| Return on Assets (TTM) | 35.86% | 11.93% | Supreme Petrochem |
| Free Cash Flow (TTM) | N/A | $1.11B | N/A |
| Dividend Yield | N/A | 0.08% | N/A |
| 1-Year Return | 2.01% | 11.11% | Neuland Laboratories |
| Price-to-Sales Ratio (TTM) | 1.43 | 14.67 | Supreme Petrochem |
| Enterprise Value | $69.88B | $194.32B | Neuland Laboratories |
| EV/Revenue Ratio | 1.39 | 14.61 | Supreme Petrochem |
| Gross Profit Margin (TTM) | 22.66% | 47.77% | Neuland Laboratories |
| Revenue per Share (TTM) | $534 | $1,037 | Neuland Laboratories |
| Earnings per Share (Diluted) | $70.54 | $136.89 | Neuland Laboratories |
| Beta (Stock Volatility) | N/A | 0.07 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Supreme Petrochem vs Neuland Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Supreme Petrochem | -2.00% | -3.08% | 2.43% | -1.30% | 38.93% | 20.64% |
| Neuland Laboratories | 4.41% | 8.39% | 9.56% | 34.32% | 44.41% | 10.75% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Supreme Petrochem | 2.01% | 7.05% | 226.42% | 587.18% | 1,007.41% | 2,329.97% |
| Neuland Laboratories | 11.11% | 936.70% | 1,274.52% | 1,950.78% | 15,796.17% | 18,428.79% |
News Based Sentiment: Supreme Petrochem vs Neuland Laboratories
Supreme Petrochem
News based Sentiment: MIXED
October brought both positive developments – expansion of production capacity and bullish analyst ratings – and some volatility in share price. While the expansion signals long-term growth potential, the short-term price fluctuations and trading window closure create a mixed investment picture.
Neuland Laboratories
News based Sentiment: MIXED
Neuland Laboratories reported a strong Q3 FY25 but followed it with a significant revenue decline in Q1 FY26. This mixed performance, coupled with shifts in shareholding, creates a complex investment picture requiring careful monitoring. The changes in institutional investor activity also add to the uncertainty.
Performance & Financial Health Analysis: Supreme Petrochem vs Neuland Laboratories
| Metric | SUPPETRO | NEULANDLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹71.68B | ₹194.55B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 6,027 | 44,411 |
| 90 Day Avg. Volume | 9,254 | 51,849 |
| Last Close | ₹806.75 | ₹15,831.00 |
| 52 Week Range | ₹518.05 - ₹981.65 | ₹10,190.70 - ₹18,100.00 |
| % from 52W High | -17.82% | -12.54% |
| All-Time High | ₹1,027.05 (Mar 28, 2022) | ₹18,100.00 (Dec 02, 2024) |
| % from All-Time High | -21.45% | -12.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | -0.33% |
| Quarterly Earnings Growth | 0.42% | -0.86% |
| Financial Health | ||
| Profit Margin (TTM) | 0.23% | 0.13% |
| Operating Margin (TTM) | N/A | 0.05% |
| Return on Equity (TTM) | 2.19% | 0.17% |
| Debt to Equity (MRQ) | 0.12 | 10.31 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹32.19 | ₹1,188.48 |
| Cash per Share (MRQ) | ₹17.07 | ₹186.76 |
| Operating Cash Flow (TTM) | ₹9.01B | ₹3.44B |
| Levered Free Cash Flow (TTM) | ₹6.63B | ₹2.60B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.08% |
| Last 12-Month Dividend | ₹0.00 | ₹12.00 |
Valuation & Enterprise Metrics Analysis: Supreme Petrochem vs Neuland Laboratories
| Metric | SUPPETRO | NEULANDLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 150.56 | 111.11 |
| Forward P/E | 30.57 | 41.03 |
| PEG Ratio | 3.83 | -1.29 |
| Price to Sales (TTM) | 1.43 | 14.67 |
| Price to Book (MRQ) | 5.62 | 12.80 |
| Market Capitalization | ||
| Market Capitalization | ₹71.68B | ₹194.55B |
| Enterprise Value | ₹69.88B | ₹194.32B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.39 | 14.61 |
| Enterprise to EBITDA | 7.63 | 83.57 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.07 |
| Book Value per Share (MRQ) | ₹32.19 | ₹1,188.48 |
Financial Statements Comparison: Supreme Petrochem vs Neuland Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SUPPETRO | NEULANDLAB |
|---|---|---|
| Revenue/Sales | N/A | ₹2.93B |
| Cost of Goods Sold | N/A | ₹1.53B |
| Gross Profit | N/A | ₹1.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | ₹142.99M |
| EBITDA | N/A | ₹423.45M |
| Pre-Tax Income | N/A | ₹175.70M |
| Income Tax | N/A | ₹36.70M |
| Net Income (Profit) | N/A | ₹139.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SUPPETRO | NEULANDLAB |
|---|---|---|
| Cash & Equivalents | N/A | ₹1.32B |
| Total Current Assets | N/A | ₹11.39B |
| Total Current Liabilities | N/A | ₹4.66B |
| Long-Term Debt | N/A | ₹1.09B |
| Total Shareholders Equity | N/A | ₹15.25B |
| Retained Earnings | N/A | ₹9.95B |
| Property, Plant & Equipment | N/A | ₹6.74B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SUPPETRO | NEULANDLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SUPPETRO | NEULANDLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,027 | 44,411 |
| Average Daily Volume (90 Day) | 9,254 | 51,849 |
| Shares Outstanding | 94.02M | 12.83M |
| Float Shares | N/A | 7.19M |
| % Held by Insiders | N/A | 0.38% |
| % Held by Institutions | N/A | 0.26% |
Dividend Analysis & Yield Comparison: Supreme Petrochem vs Neuland Laboratories
| Metric | SUPPETRO | NEULANDLAB |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹12.00 |
| Last 12-Month Dividend Yield | N/A | 0.08% |
| 3-Year Avg Annual Dividend | ₹9.33 | ₹12.00 |
| 3-Year Avg Dividend Yield | 1.63% | 0.20% |
| 3-Year Total Dividends | ₹28.00 | ₹36.00 |
| Ex-Dividend Date | Jul 25, 2022 | Jul 18, 2025 |